Detalles de la búsqueda
1.
Treatment Strategy for Rifampin-Susceptible Tuberculosis.
N Engl J Med
; 388(10): 873-887, 2023 Mar 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-36808186
2.
Adjunctive pascolizumab in rifampicin-susceptible pulmonary tuberculosis: proof-of-concept, partially-randomised, double-blind, placebo-controlled, dose-escalation trial.
J Infect Dis
; 2024 Mar 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-38527849
3.
Effects of Increasing Concentrations of Rifampicin on Different Mycobacterium tuberculosis Lineages in a Whole-Blood Bactericidal Activity Assay.
Antimicrob Agents Chemother
; 66(2): e0169921, 2022 02 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-34871090
4.
The Singapore Asymptomatic Narrow Angles Laser Iridotomy Study: Five-Year Results of a Randomized Controlled Trial.
Ophthalmology
; 129(2): 147-158, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34453952
5.
Frequency and Clinical Impact of Serious Adverse Events on Post-Stroke Recovery with NeuroAiD (MLC601) versus Placebo: The CHInese Medicine Neuroaid Efficacy on Stroke Recovery Study.
Cerebrovasc Dis
; 49(2): 192-199, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32126551
6.
Coadministration of Allopurinol To Increase Antimycobacterial Efficacy of Pyrazinamide as Evaluated in a Whole-Blood Bactericidal Activity Model.
Antimicrob Agents Chemother
; 61(10)2017 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-28739782
7.
Activity of faropenem with and without rifampicin against Mycobacterium tuberculosis: evaluation in a whole-blood bactericidal activity trial.
J Antimicrob Chemother
; 72(7): 2012-2019, 2017 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28333342
8.
Five-Year Clinical Trial on Atropine for the Treatment of Myopia 2: Myopia Control with Atropine 0.01% Eyedrops.
Ophthalmology
; 123(2): 391-399, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26271839
9.
Emergency Department Management of Sepsis Patients: A Randomized, Goal-Oriented, Noninvasive Sepsis Trial.
Ann Emerg Med
; 67(3): 367-378.e3, 2016 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-26475246
10.
Letter to the Editor Following "Prospective Clinical Trial Comparing Outcome Measures Between Furlow and von Langenbeck Palatoplasties for UCLP" by William N. Williams, M. Brent Seagle, Maria Ines Pegoraro-Krook, et al. Annals of Plastic Surgery, 2011.
Ann Plast Surg
; 85(1): 94-95, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31800558
11.
Supplementation with probiotics in the first 6 months of life did not protect against eczema and allergy in at-risk Asian infants: a 5-year follow-up.
Int Arch Allergy Immunol
; 163(1): 25-8, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-24247661
12.
Rosuvastatin adjunctive therapy for rifampicin-susceptible pulmonary tuberculosis: a phase 2b, randomised, open-label, multicentre trial.
Lancet Infect Dis
; 23(7): 847-855, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-36966799
13.
Analysis of time-to-event data with nonuniform patient entry and loss to follow-up under a two-stage seamless adaptive design with weibull distribution.
J Biopharm Stat
; 22(4): 773-84, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-22651114
14.
Alzheimer's Disease THErapy With NEuroaid (ATHENE): A Randomized Double-Blind Delayed-Start Trial.
J Am Med Dir Assoc
; 23(3): 379-386.e3, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34856171
15.
Pre- and apnoeic high-flow oxygenation for rapid sequence intubation in the emergency department (the Pre-AeRATE trial): A multicentre randomised controlled trial.
Ann Acad Med Singap
; 51(3): 149-160, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-35373238
16.
NEURoaid II (MLC901) in cognitively Impaired not demenTEd patientS (NEURITES): A pilot double blind, placebo-controlled randomized trial.
Alzheimers Dement (N Y)
; 7(1): e12161, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33816765
17.
Analysis of time-to-event data under a two-stage survival adaptive design in clinical trials.
J Biopharm Stat
; 20(4): 705-19, 2010 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-20496201
18.
Statistical methods for assessment of biosimilarity using biomarker data.
J Biopharm Stat
; 20(1): 90-105, 2010 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-20077251
19.
On assessing bioequivalence using genomic data with model misspecification.
J Biopharm Stat
; 19(4): 571-9, 2009 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-20183426
20.
Sample size estimation based on event data for a two-stage survival adaptive trial with different durations.
J Biopharm Stat
; 19(2): 311-23, 2009.
Artículo
en Inglés
| MEDLINE | ID: mdl-19212882